Saltar al contenido
Merck
Todas las fotos(1)

Documentos clave

Ver Toda la documentación

Y0000382

Famotidine for system suitability

European Pharmacopoeia (EP) Reference Standard

Sinónimos:

Famotidine, N′-(Aminosulfonyl)-3-([2-(diaminomethyleneamino)-4-thiazolyl]methylthio)propanamidine

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

Fórmula empírica (notación de Hill):
C8H15N7O2S3
Número de CAS:
76824-35-6
Peso molecular:
337.45
Número MDL:
MFCD00079297
Código UNSPSC:
41116107
ID de la sustancia en PubChem:
329830928
NACRES:
NA.24
En este momento no podemos mostrarle ni los precios ni la disponibilidad

grado

pharmaceutical primary standard

familia API

famotidine

fabricante / nombre comercial

EDQM

aplicaciones

pharmaceutical (small molecule)

Formato

neat

temp. de almacenamiento

2-8°C

cadena SMILES

N\C(N)=N\c1nc(CSCCC(=N)NS(N)(=O)=O)cs1

InChI

1S/C8H15N7O2S3/c9-6(15-20(12,16)17)1-2-18-3-5-4-19-8(13-5)14-7(10)11/h4H,1-3H2,(H2,9,15)(H2,12,16,17)(H4,10,11,13,14)

Clave InChI

XUFQPHANEAPEMJ-UHFFFAOYSA-N

Información sobre el gen

human ... HRH2(3274)

¿Está buscando productos similares? Visita Guía de comparación de productos

Descripción general

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Aplicación

Famotidine for system suitability EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Acciones bioquímicas o fisiológicas

H2 histamine receptor antagonist; anti-ulcer agent

Envase

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Otras notas

Sales restrictions may apply.

Producto relacionado

Referencia del producto
Descripción
Precios

PHR1055

Famotidine, Pharmaceutical Secondary Standard; Certified Reference Material

F0005000

Famotidine, European Pharmacopoeia (EP) Reference Standard

Y0000409

Famotidine impurity D, European Pharmacopoeia (EP) Reference Standard

1269200

Famotidine, United States Pharmacopeia (USP) Reference Standard

1269243

Famotidine Related Compound D, United States Pharmacopeia (USP) Reference Standard

1269265

Famotidine Related Compound F, United States Pharmacopeia (USP) Reference Standard

1269221

Famotidine Related Compound B, United States Pharmacopeia (USP) Reference Standard

1269232

Famotidine Related Compound C, United States Pharmacopeia (USP) Reference Standard

1269254

Famotidine Related Compound E, United States Pharmacopeia (USP) Reference Standard

BP653

Famotidine, British Pharmacopoeia (BP) Reference Standard

PHR2908

Famotidine Related Compound F, certified reference material, pharmaceutical secondary standard

PHR2909

Famotidine Related Compound B, certified reference material, pharmaceutical secondary standard

PHR2910

Famotidine Related Compound C

PHR2911

Famotidine Related Compound D

Código de clase de almacenamiento

11 - Combustible Solids

Clase de riesgo para el agua (WGK)

WGK 2

Punto de inflamabilidad (°F)

Not applicable

Punto de inflamabilidad (°C)

Not applicable

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Si necesita más asistencia, póngase en contacto con Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

I C Wesdorp
Hepato-gastroenterology, 39 Suppl 1, 24-26 (1992-02-01)
Famotidine, a potent and long-acting H2-receptor antagonist, has been evaluated in patients with gastroesophageal reflux disease (GERD). From intraesophageal pH monitoring and clinical studies, b.i.d. dosing of this selective compound is necessary for achieving adequate results. The results of large
K Yoshimoto et al.
Clinical pharmacology and therapeutics, 55(6), 693-700 (1994-06-01)
Central nervous system toxicity of H2-receptor antagonists has rarely been confirmed by the respective elevated cerebrospinal fluid drug concentrations. We observed two hemodialyzed neurosurgical patients in whom mental deterioration and convulsions developed after intravenous famotidine therapy (10 and 40 mg/day).
H D Langtry et al.
Drugs, 38(4), 551-590 (1989-10-01)
Famotidine is a highly selective histamine H2-receptor antagonist. In healthy volunteers and patients with acid hypersecretory disease it is approximately 20 to 50 times more potent at inhibiting gastric acid secretion than cimetidine and 8 times more potent than ranitidine
Michael Schiff et al.
Expert review of gastroenterology & hepatology, 6(1), 25-35 (2011-12-14)
Arthritis affects nearly 50 million people in the USA and, with the aging of the population, the prevalence is expected to rise. While NSAIDs are very effective in relieving pain associated with osteoarthritis (OA) and rheumatoid arthritis (RA), they are
[Famotidine--a new histamine H2 receptor blockader].
P Ia Grigor'ev et al.
Klinicheskaia meditsina, 69(4), 23-28 (1991-04-01)
Ver todos los artículos relacionados

Questions

Reviews

No rating value

Active Filters

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico